Skip to main content
Download PDF

Pre-pregnancy complications - associated factors and wellbeing in early pregnancy: a Swedish cohort study

BMC Pregnancy and Childbirth volume 23, Article number: 153 (2023) Cite this article

Abstract

Background

Many couples experience difficulties to become pregnant or carry a pregnancy to term due to unknown causes. Here we define pre-pregnancy complications as having prior recurrent pregnancy loss, prior late miscarriages, time to pregnancy more than one year, or the use of artificial reproductive technologies. We aim to identify factors associated with pre-pregnancy complications and poor well-being in early pregnancy.

Methods

Online questionnaire data from 5330 unique pregnancies in Sweden were collected from November 2017 – February 2021. Multivariable logistic regression modelling was used to investigate potential risk factors for pre-pregnancy complications and differences in early pregnancy symptoms.

Results

Pre-pregnancy complications were identified in 1142 participants (21%). Risk factors included diagnosed endometriosis, thyroid medication, opioids and other strong pain medication, body mass index > 25 kg/m2 and age over 35 years. Different subgroups of pre-pregnancy complications had unique risk factors. The groups also experienced different pregnancy symptoms in early pregnancy, where women that had experienced recurrent pregnancy loss were at higher risk of depression in their current pregnancy.

Conclusion

We report one of the largest pregnancy cohorts with high frequency of pre-pregnancy complications compared to the Swedish population. Prescribed drug use and body weight were the top potentially modifiable risk factors in all groups. Participants that experienced pre-pregnancy complications also had higher risk of depression and pregnancy problems in early pregnancy.

Peer Review reports

Background

There are many unanswered questions regarding a pre-pregnancy complications and early pregnancy well-being. Pre-pregnancy complications could be due to repeated miscarriages (recurrent pregnancy loss, RPL), having experienced a late miscarriage, prolonged time to conception (subfertility) or needing assisted reproductive technologies (ART). Many couples experience difficulties to become pregnant or carry a pregnancy to term due to unknown causes.

Approximately 2.5% of women worldwide suffer from RPL [1], defined as ≥ 2 (United States) or ≥ 3 (United Kingdom) consecutive miscarriages [2]. Common causes are genetic, uterine abnormalities, endocrine disorders and obesity, but half of cases have unknown causes [2].

Subfertility is defined as failure to conceive within one year of unprotected intercourse – a delay or reduction in fertility [3]. A woman’s age is a major influence on fertility, which starts decreasing from 25 to 30 years of age [3, 4]. Overall, subfertility and infertility are estimated to affect 10–15% of couples [5]. It has been reported that pre-existent obesity [6], smoking, or excessive caffeine or alcohol consumption [4] can reduce fertility. Other causes include polycystic ovary syndrome (PCOS), endometriosis, damage to the fallopian tubes (e.g., by Chlamydia trachomatis infection) and male subfertility [3,4,5, 7]. However, many couples have unexplained subfertility [4, 5, 7]. It is estimated that 84% of couples conceive within one year of trying [4, 7], which is often used to define subfertility [8] and a common benchmark before starting ART [4].

ART include in vitro fertilization (IVF), intrauterine insemination (IUI) and intracytoplasmic sperm injection (ICSI) [4]. In Sweden, the use of IVF and ISCI has increased steadily over the last decades [9], with approximately 4.5% of children in Sweden are conceived by IVF every year [10].

Most current studies on reproductive history and pregnancy focus on birth outcome and not potential risk factors for the difficulties conceiving or maintaining the pregnancy. Fertility complications can cause increased anxiety, stress and self-blame [11], which in turn can negatively affect fertility [4, 12]. If pre-pregnancy complications affect the early phase of pregnancy and pregnancy symptoms also remains unclear. In this study, we aim to identify potential risk factors for pre-pregnancy complications, as well as assessing wellbeing in early pregnancy.

Methods

Aim

Here we use questionnaire data from the Swedish Maternal Microbiome (SweMaMi) cohort study [13] to identify potential risk factors for pre-pregnancy complications in comparison to having none.

Our second aim is to assess the differences in pre-pregnancy complications subgroups: RPL, subfertility, ART and late miscarriage, compared to the uncomplicated pre-pregnancy group and differences in early pregnancy symptoms.

Study design- and period

The SweMaMi project started enrolment in November 2017 and ended February 2021 (with last deliveries during autumn 2021). All pregnant women (before gestational week 20) residing in Sweden with a personal identification number were eligible to participate. Since no additional healthcare visits were required to participate in the study, women all over Sweden could participate [13].

The study was performed according to the Declaration of Helsinki and approved by the regional Ethics Committee of Stockholm (Dnr 2020 − 01629). The study cohort is described in detail in a cohort profile [13]. In short, participants gave their informed consent when completing the first online questionnaire. We collected data at three different timepoints, starting with an online questionnaire, followed by home-sampling for microbiome assessment: (i) Before pregnancy week 20, (ii) Pregnancy week 28–30 and (iii) 5–8 weeks postpartum.

In addition, a registry linkage will be conducted to obtain more detailed information from the Medical Birth Registry, Patient Registry and Drug Registry.

Data collection and eligibility

The three questionnaires included questions regarding pregnancy, lifestyle, physical-, mental- and reproductive health. The last questionnaire focused more on the birth itself and the infant’s health. For the present study, only the first questionnaire (baseline) is used (Supplement 1). Single women were excluded because of the potential social reasons for pre-pregnancy complications. Participants that did not answer their number of previous early miscarriages or previous late miscarriages (including intrauterine fetal demise (IUFD)) were considered as having had none. Other missing answers were regarded as missing and omitted from the multivariable analyses.

Pre-pregnancy complications

Pre-pregnancy complications were defined based on a history of (i) previous three or more early miscarriages [2], (ii) previous late miscarriage (after week 16) including IUFD, or for the current pregnancy (iii) ART (IVF, insemination, or other medically or surgical assistance), or (iv) duration exceeding one year to conceive.

Uncomplicated pre-pregnancy was defined as pregnancies with fewer than three prior early miscarriages, no late miscarriage or IUFD, less than one year to conceive and unassisted conception. If a participant did not answer a question needed for this categorization, the answer was considered uncomplicated.

Questions regarding potential risk factors were chosen from the questionnaire to estimate: (i) general health and health seeking behavior (body mass index (BMI), menstruation, cervical screening attendance, eating disorders and gynecological infections), (ii) lifestyle (age, country of birth, education level, work situation, contact with animals, smoking, mouth tobacco use and diet), (iii) drugs (drug use before pregnancy: asthma and allergy medication, anxiety, antidepressants and sleep medication, prescription free pain medication, opioids and strong pain medication, thyroid medication, blood pressure medication, stomach acid medication and other medication), (iv) reproductive health (first pregnancy and contraceptive use) and (v) comorbidities (diagnosed and suspected endometriosis and polycystic ovary syndrome (PCOS)) (Supplement 1). Participants were sorted as having suspected PCOS if they reported Ferriman-Gallwey score ≥ 8 [14] or hair loss grade 3, and suspected endometriosis if they reported vaginal spotting before the start of menstruation [15, 16].

General health problems

To estimate the effect of general health prior to pregnancy on the risk of pre-pregnancy complications, six categories were created based on reported medical history: (i) Gynecological history (diagnosed or suspected endometriosis or PCOS), (ii) Non-gastrointestinal chronic inflammatory diseases (diagnosed rheumatoid arthritis, autoimmune diseases or multiple sclerosis (MS)), (iii) Gastrointestinal problems (gastric acid medication, diagnosed Crohn’s disease or ulcerative colitis), (iv) Mental health (eating disorder, anti-depressive-, anti-anxiety- or sleeping medication), (v) Chronic respiratory diseases and allergies (asthma, hay fever, allergies, asthma- or allergy medication) and (vi) Endocrine indications (thyroid medication or diagnosed hypothyroidism). These categories were not mutually exclusive. Participants with each comorbidity were compared to those without the specific comorbidity; and the group with any of these comorbidities was also compared to those without.

Early pregnancy well-being and characteristics

To assess if early pregnancy well-being and characteristics are different among participants with pre-pregnancy complications compared to those without, data regarding depressive symptoms (Edinburgh Postnatal Depression Scale [17]), stress (Cohen Perceived Stress Scale [18]), bowel symptoms (Bristol stool form scale [19]), pregnancy problems, vomiting and nausea [20], self-reported general health estimate, alcohol consumption [21] and medication (drug use during pregnancy: asthma and allergy medication, anxiety, antidepressants and sleep medication, prescription free pain medication, opioids and strong pain medication, thyroid medication, blood pressure medication, stomach acid medication and other medication) were extracted from the questionnaire.

Statistical analyses

Statistical analyses were conducted in Excel (version 2108) and RStudio (version 1.3.1093). Descriptive statistics are presented as absolute numbers, percentages and means with standard deviation.

Multivariable logistic regression modelling was used to investigate potential risk factors as exposure with pre-pregnancy complications (and its subgroups) as outcome, using the total group with an uncomplicated pre-pregnancy onset as reference for all analyses. The same method was used for the different categories of health problems.

Multivariable logistic regression was then performed to investigate the odds of early pregnancy symptoms as outcome, in participants with pre-pregnancy complications as exposure.

All results (independent of statistical significance) are presented as odds ratios (OR) and 95% confidence intervals.

Results

Out of the total 5330 eligible pregnancies (5144 unique participants), 1142 (21%) were categorized as having pre-pregnancy complications (Table 1). Out of the pre-pregnancy complications, 220 (19%) participants had suffered RPL, 790 (69%) subfertility, 96 (8%) had a previous late miscarriage and 540 (47%) used ART (Fig. 1). The largest overlap comprised subfertile participants who got pregnant with the help of ART (n = 327, 29%), and subfertile participants who experienced RPL (n = 65, 6%) (Fig. 1). The mean time to get pregnant was 19 months for the pre-pregnancy complications group and 2 months for the uncomplicated group.

Table 1 Definitions of pre-pregnancy complications and uncomplicated pre-pregnancy
Full size table
Fig. 1
figure 1

Categorization of the cohort as uncomplicated pre-pregnancy and pre-pregnancy complications with subgroups. Generated with BioRender

Full size image

The average gestational length when answering the questionnaire was similar in all four subgroups of pre-pregnancy complications and uncomplicated pre-pregnancy (12 weeks), allowing comparison for pregnancy related questions, such as pregnancy problems and symptoms.

Characteristics of pre-pregnancy complications

The pre-pregnancy complications group was more likely to be overweight (BMI > 25 kg/m2) or obese (BMI > 30 kg/m2) (35% vs. 28%) and older than 35 years (37% vs. 20%) than the uncomplicated pre-pregnancy group. Country of birth, education level and working situation were similar for both groups (Supplementary Table 1). Characteristics with between-group differences larger than over 10% were listed in Fig. 2.

Fig. 2
figure 2

Descriptive statistics of the uncomplicated pre-pregnancy and pre-pregnancy complications group, and its subgroups, where the difference between the highest and lowest subgroup value was over 10%. Complete dataset in Supplementary Table 3

Full size image

Characteristics of the subgroups of pre-pregnancy complications

Descriptive analyses showed that out of the four complicated subgroups, participants who experienced RPL had the highest prevalence of using asthma or allergy medication (21% vs. 15% uncomplicated) and the lowest representation of vegetarians (9% vs. 18% uncomplicated) (Supplementary Tables 1, Fig. 2). Subfertile participants were the youngest of the complication’s subgroups (22% under 30 years old vs. 33% uncomplicated). Out of the four subgroups, participants becoming pregnant via ART had the highest prevalence of completed university education (86% vs. 78% uncomplicated), having diagnosed endometriosis (12% vs. 2% uncomplicated) and PCOS (24% vs. 6%) and reported irregular menstruation prior to this pregnancy (29% vs. 16% uncomplicated).

Factors associated with pre-pregnancy complications

The following factors were identified as being associated with pre-pregnancy complications compared to uncomplicated: age ≥ 35 years (OR 2.84, CI 1.90–4.40), being overweight or obese (OR 1.35, CI 1.07–1.72 for overweight and OR 1.58, CI 1.19–2.07 for obese), born outside Sweden (OR 1.42, CI 1.15-1-76), irregular menstruation (OR 1.59, CI 1.35–1.87), diagnosed (OR 4.43, CI 3.33–5.91) and suspected (OR 1.29, CI 1.09–1.51) endometriosis, diagnosed PCOS (OR 2.89, CI 2.35–3.54), regular contact with animals (OR 1.17, CI 1.03–1.34), and the use of certain drugs prior to pregnancy (asthma and allergy medication (OR 1.23, CI 1.03–1.46), opioids and strong pain medication (OR 1.97, CI 1.19–3.19) and thyroid medication (OR 2.20, CI 1.76–2.74) (Supplementary Table 2).

Logistic regression for RPL, subfertility and ART showed that they had different and sometimes unique risk factors (Supplementary Tables 2, Fig. 3). The late miscarriage subgroup was not included because of the small group size (n = 96).

Fig. 3
figure 3

Venn diagram of risk factors for the different categories of pre-pregnancy complications, shown with percentage of complicated cases. Overlapping circles show risk factors for multiple groups. Generated with BioRender

Full size image

Unique risk factors for the RPL group were not having attended cervical screening (OR 1.69, CI 1.00-2.69), being a current smoker (OR 4.39, CI 2.06–8.51), and lower education levels (OR 3.64, CI 1.65–7.17 for primary school as highest education level and OR 1.49, CI 1.06–2.05 for senior high school as highest education level). Furthermore, being vegetarian appeared protective for the RPL group (OR 0.45, CI 0.27–0.70).

Unique risk factors for subfertility were country of birth outside Sweden (OR 1.58, CI 1.24-2.00) and use of prescription-free pain medication prior to pregnancy (OR 1.22, CI 1.03–1.44).

Moreover, the unique risk factors for ART were age 30–34 years (OR 2.77, CI 1.38–5.59), and being vegetarian (OR 1.27, CI 1.01–1.58), and senior high school education level protective (OR 0.59, CI 0.45–0.78).

General health and the risk of pre-pregnancy complications

Out of the total cohort (n = 5330), 65% belonged to at least one category of health estimation – indicating that only one third of the cohort could be regarded as entirely “healthy” according to our categorization (Supplementary Table 3). There were higher odds for pre-pregnancy complications in all the six subgroups, except for chronic inflammatory diseases which showed no association (OR 0.98, CI 0.62–1.51).

Having gynecological (OR 1.94, CI 1.71–2.24), endocrine comorbidities (OR 1.70, CI 1.40–2.06) or belonging to any of the six chronic comorbidities categories (OR 1.69, CI 1.46–1.97) increased the risk of pre-pregnancy complications (Fig. 4). For participants that had chronic respiratory diseases and allergies (OR 1.36, CI 1.02–1.80), the risk of RPL was also significantly higher (Supplementary Table 3). The late miscarriage group was excluded from individual analysis because of sample size.

Fig. 4
figure 4

Forest plot showing odds of a pre-pregnancy complications by underlying comorbidities, with 95% confidence intervals. Not having the specific comorbidity was used as reference. Power of each analysis is indicated by the size of the gray boxes

Full size image

Early pregnancy well-being for pre-pregnancy complications subgroups

Compared to uncomplicated pre-pregnancy, participants who had pre-pregnancy complications were more likely to have experienced pregnancy-related problems (17% vs. 13% uncomplicated), where depression (3% vs. 1% uncomplicated), vaginal bleeding (4% vs. 2% uncomplicated) and acid reflux (6% vs. 4% uncomplicated) were the most common problems observed in our cohort (Supplementary Table 4).

Similar percentage of participants in both the complicated and uncomplicated pre-pregnancy groups considered their health as either very good or pretty good (90% vs. 92% uncomplicated). Participants that had suffered RPL or a late miscarriage had the highest perceived stress (mean 5.77 and 5.86 respectively vs. 5.43 for uncomplicated) and scored highest on the EPDS (mean 8.17 and 8.71 respectively vs. 7.02 for uncomplicated). Out of all four subgroups, participants in the late miscarriage group had highest prevalence of nausea for more than 6 h daily (20% vs. 15% uncomplicated).

Risk factors for experiencing physical and psychological symptoms

Out of the subgroups, participants that had experienced RPL showed a significantly higher risk of depression (OR 1.71, CI 1.21–2.38) and constipation (OR 1.36, CI 1.02–1.80) (Supplementary Table 4).

All groups showed higher risk of pregnancy problems and taking opioids and strong pain medication, thyroid medication and other medication during pregnancy (Supplementary Table 4).

Discussion

Besides the known risk factors age and overweight/obesity [2,3,4, 6], prescribed drug use stood out as a factor associated with being in almost all groups with pre-pregnancy complications, yet we cannot distinguish between the effect of the drugs and confounding by indication. The RPL group seemed to have the most socio-economic risk factors, including low education, smoking and having never attended cervical screening, which could indicate more limited healthcare-seeking behavior. The ART and subfertility groups were largely overlapping considering risk factors, as were the subfertility group and overall pre-pregnancy complications. For subfertility and ART, higher education level, having a job, no use of contraceptives and higher age could be risk factors since the participants have likely attempted pregnancy for a long time before being categorized as subfertile or qualifying for ART.

Our results also point to a difference in early pregnancy well-being, where participants with pre-pregnancy complications tend to have higher levels of anxiety and depression, are more likely to have experienced any pregnancy complications and have used drugs during pregnancy than the uncomplicated group.

Very little research has been conducted on pre-pregnancy complications. Endometriosis, PCOS and age have previously been described as risk factors for subfertility [3,4,5, 7]. In line with earlier studies, we also found that endocrine and gynecological comorbidities had the biggest effect on the risk of pre-pregnancy complications. Moreover, with our extensive questionnaires, we were also able to identify certain prescribed drug groups and country of birth (thereby, being an immigrant) as possible risk factors.

Modifiable factors such as weight loss, smoking cessation, and only taking drugs when truly needed (and doing so with proper guidance) could potentially increase the chances of an uncomplicated pre-pregnancy. Our results also suggest that the microbiome might have a role in the risk of RPL, where drugs had the highest effect [22, 23]. However, potential confounding by indication needs to be addressed.

Currently there is no standardized approach for RPL in Sweden, due to many cases have unknown causes and the molecular mechanisms of RPL are greatly understudied [24]. Knowledge of the identified risk factors might assist the healthcare system to identify women at higher risk of subfertility and/or RPL and follow them up more closely with support and counsel when trying to conceive. Individuals at risk might be aided through nutritional advise to help weight loss, overview of medicinal intake or psychotherapy to minimize the risk of stress and depression. The risk factors found in our study could also be used to increase fertility awareness. Further studies are needed to better understand the effect of certain drug groups and the underlying mechanisms of their risks for each subgroup of pre-pregnancy complications.

We constructed one of the largest pregnancy cohorts enrolling women from all over Sweden with detailed, standardized and validated questions. With over 5300 women in our cohort we represent approximately 1.5% of all pregnancies in Sweden during the study period (estimated 115–120,000 pregnancies each year [10]). We have a high number of participants from the Stockholm region (c. 40% of total cohort) and high education level, which can be expected in scientific studies with population-wide enrollment. Furthermore, participants born outside of Sweden are underrepresented, possibly because of language barriers. However, in our recent cohort profile [13], we found that our cohort was fairly representative of the Swedish pregnant population.

To our knowledge, this is the first large study to estimate the risk factors for pre-pregnancy complications, and how pre-pregnancy complications displays in early pregnancy.

There are also limitations of this study. Some participants did not answer all the questions, for example number of previous early miscarriages (n = 1572, 30% of cohort), which were interpreted as having had none. Furthermore, we do not have information on the partner’s medical history, so we cannot exclude the subfertility and the need for ART might be due to the partner’s condition. We also have a high prevalence of participants with RPL, 4.1% (compared to estimated 2.5% worldwide [1]), and IVF, 5.8% (compared to 4.5% in Sweden yearly [10]), which might indicate a slight selection bias towards participants with complicated pregnancy onset. Because of their past experiences, RPL participants might be more eager to participate and contribute to research in this field. It could also point to an underestimation of RPL in the literature, since most miscarriages occur before 12 completed weeks of pregnancy, before many women are registered pregnant in the healthcare system, and therefore are not counted in the population statistics. The same holds true for a high number of women with suspected PCOS and endometriosis in the cohort, two gynecological comorbidities which are vastly underdiagnosed in the general population [25, 26], but have a great impact on pregnancy onset.

Further research on women’s health and pre-pregnancy complications is of high importance, since so many women and couples suffer involuntary childlessness, problems to get pregnant or stay pregnant, with no answers to the underlying cause.

Conclusion

We reported one of the largest pregnancy cohorts with high frequency of pre-pregnancy complications (21%). We evaluated and presented different risk profiles for four pre-pregnancy complications subgroups: RPL, subfertility, ART and late miscarriage. Prescribed drug use and body weight are the major potentially modifiable risk factors in all groups. Furthermore, women with a pre-pregnancy complications had a higher risk of pregnancy complications in their current pregnancy. The identified risk factors could be used to identify women at risk for pre-pregnancy complications and help them earlier in the process of trying to conceive, thus assisting them to reduce stress and depression during the pregnancy.

Data availability

The datasets analyzed during the current study are not publicly available because of the high detail of clinical and personal information (despite being depersonified) - but are available from the corresponding author on reasonable request.

Abbreviations

ART:

Assisted reproductive technologies

BMI:

Body mass index

CI:

Confidence interval

ICSI:

Intracytoplasmic sperm injection

IUFD:

Intrauterine fetal demise

IUI:

Intrauterine insemination

IVF:

In vitro fertilization

MS:

Multiple sclerosis

OR:

Odds ratio

PCOS:

Polycystic ovary syndrome

RPL:

Recurrent pregnancy loss

References

  1. Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98.

    Article  PubMed  Google Scholar 

  2. Pillarisetty LS, Gupta N. Recurrent Pregnancy Loss. StatPearls. Treasure Island (FL)2021.

  3. Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2–10.

    Article  PubMed  Google Scholar 

  4. Farquhar CM, Bhattacharya S, Repping S, Mastenbroek S, Kamath MS, Marjoribanks J, et al. Female subfertility. Nat Rev Dis Primers. 2019;5(1):7.

    Article  PubMed  Google Scholar 

  5. Evers JL. Female subfertility. Lancet. 2002;360(9327):151–9.

    Article  PubMed  Google Scholar 

  6. Hurter H, van Vontelin S, Vokalova L, Brandl M, Baumann M, Hosli I, et al. Prevention of pre-eclampsia after infertility treatment: Preconceptional minimalisation of risk factors. Best Pract Res Clin Endocrinol Metab. 2019;33(1):127–32.

    Article  PubMed  Google Scholar 

  7. Thurston L, Abbara A, Dhillo WS. Investigation and management of subfertility. J Clin Pathol. 2019;72(9):579–87.

    Article  CAS  PubMed  Google Scholar 

  8. Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges J, Freundl G. Definition and prevalence of subfertility and infertility. Hum Reprod. 2005;20(5):1144–7.

    Article  CAS  PubMed  Google Scholar 

  9. Socialstyrelsen. Graviditeter, förlossningar och nyfödda barn. Socialstyrelsen; 2015. https://www.socialstyrelsen.se/

    Google Scholar 

  10. Socialstyrelsen. Statistik om graviditeter, förlossningar och nyfödda 2021 [Available from: https://www.socialstyrelsen.se/statistik-och-data/statistik/statistikamnen/graviditeter-forlossningar-och-nyfodda/

  11. Iordachescu DA, Paica CI, Boca AE, Gica C, Panaitescu AM, Peltecu G et al. Anxiety, Difficulties, and Coping of Infertile Women. Healthcare (Basel). 2021;9(4).

  12. Simionescu G, Doroftei B, Maftei R, Obreja BE, Anton E, Grab D, et al. The complex relationship between infertility and psychological distress (review). Exp Ther Med. 2021;21(4):306.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Fransson E, Gudnadottir U, Hugerth LW, Itzel EW, Hamsten M, Boulund F, et al. Cohort profile: the swedish maternal microbiome project (SweMaMi) - assessing the dynamic associations between the microbiome and maternal and neonatal adverse events. BMJ Open. 2022;12(10):e065825.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–7.

    Article  CAS  PubMed  Google Scholar 

  15. Hickey M, Ballard K, Farquhar C, Endometriosis. BMJ. 2014;348:g1752.

    Article  PubMed  Google Scholar 

  16. Heitmann RJ, Langan KL, Huang RR, Chow GE, Burney RO. Premenstrual spotting of >/=2 days is strongly associated with histologically confirmed endometriosis in women with infertility. Am J Obstet Gynecol. 2014;211(4):358e1–6.

    Article  Google Scholar 

  17. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh postnatal depression scale. Br J Psychiatry. 1987;150:782–6.

    Article  CAS  PubMed  Google Scholar 

  18. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–96.

    Article  CAS  PubMed  Google Scholar 

  19. Amarenco G. Bristol Stool Chart: prospective and monocentric study of “stools introspection” in healthy subjects. Prog Urol. 2014;24(11):708–13.

    Article  CAS  PubMed  Google Scholar 

  20. Ebrahimi N, Maltepe C, Bournissen FG, Koren G. Nausea and vomiting of pregnancy: using the 24-hour pregnancy-unique quantification of Emesis (PUQE-24) scale. J Obstet Gynaecol Can. 2009;31(9):803–7.

    Article  PubMed  Google Scholar 

  21. Babor T, Higgins-Biddle JC, Saunders JB, Monteiro M. The Alcohol Use Disorders Identification Test (AUDIT). In: Dependence DoMHaS, editor. World Health Organisation; 2001.

  22. Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, et al. Population-level analysis of gut microbiome variation. Science. 2016;352(6285):560–4.

    Article  CAS  PubMed  Google Scholar 

  23. Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016;352(6285):565–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. SFOG. Behandling vid oförklarade upprepade missfall sfog.se; 2017.

  25. Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354. e1- e12.

    Article  Google Scholar 

  26. Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity. Int J Environ Res Public Health. 2018;15(11).

Download references

Acknowledgements

We thank all the participants of the SweMaMi study.

We thank Laura Poole, Caroline Bjurnemark, Linn Flygare Wallen, Marica Hamsten, Kim Wong, Alexandra Pennhag and Pia Angelidou for their help with the SweMaMi project.

Funding

The Centre for Translational Microbiome Research is partly funded by Ferring Pharmaceuticals.

Open access funding provided by Karolinska Institute.

Open access funding provided by Karolinska Institute.

Author information

Authors and Affiliations

  1. Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Solna, Sweden

    Unnur Gudnadottir, Juan Du, Luisa W. Hugerth, Lars Engstrand, Ina Schuppe-Koistinen, Emma Fransson & Nele Brusselaers

  2. Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden

    Luisa W. Hugerth

  3. Science for Life Laboratory, 171 65, Solna, Sweden

    Ina Schuppe-Koistinen

  4. Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden

    Eva Wiberg Itzel

  5. Department of Women’s and Children’s health, Uppsala University, 751 85, Uppsala, Sweden

    Emma Fransson

  6. Global Health Institute, University of Antwerp, 2610, Antwerp, Belgium

    Nele Brusselaers

  7. Department of Head and Skin, Ghent University, 9000, Ghent, Belgium

    Nele Brusselaers

Authors
  1. Unnur Gudnadottir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luisa W. Hugerth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lars Engstrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ina Schuppe-Koistinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eva Wiberg Itzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Emma Fransson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Nele Brusselaers
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceived (UG, LE, ISK, EWI, EF, NB), planned (UG, JD, LE, ISK, EWI, EF, NB), carried out (UG, ISK, EF, NB), analyzed (UG, LWH, EF) and written (UG). All authors thoroughly revised the manuscript. NB guarantor of the study.

Corresponding author

Correspondence to Unnur Gudnadottir.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the regional Ethics Committee of Stockholm (Dnr 2020 − 01629).

Consent for publication

Not applicable.

Competing interests

The authors declare they have no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1

Supplementary material 2

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gudnadottir, U., Du, J., Hugerth, L.W. et al. Pre-pregnancy complications - associated factors and wellbeing in early pregnancy: a Swedish cohort study. BMC Pregnancy Childbirth 23, 153 (2023). https://doi.org/10.1186/s12884-023-05479-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12884-023-05479-8

Keywords

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us